Investors

Invest in BraineHealth’s future with US Patent 11,908,579 B2 and Diagnosio’s 99% accurate AI diagnostics.

Our inversion technology, featured in BizWeekly.com and AP across 450+ outlets, scales to 20,000+ cases and targets the $500B AI healthcare market by 2032. Outperforming Microsoft’s MAI-DxO, this innovation spans healthcare, finance, and engineering. Join us as an investor or licensee.

Investment Opportunities:

Licensing Revenue: Monetize our patented AI technology.

Equity Growth: Participate in a high-potential market leader.

License the Patent

Contact Us to explore investment opportunitites.